Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders

PO G Arkhammar, TB Bodvarsdottir… - Current medicinal …, 2004 - ingentaconnect.com
The pattern of insulin release is crucial for regulation of glucose and lipid haemostasis.
Deficient insulin release causes hyperglycemia and diabetes, whereas excessive insulin …
被引用次数：92 相关文章

Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders.

JB Hansen, PO Arkhammar… - Current Medicinal …, 2004 - europepmc.org
The pattern of insulin release is crucial for regulation of glucose and lipid haemostasis.
Deficient insulin release causes hyperglycemia and diabetes, whereas excessive insulin …

Inhibition of Insulin Secretion as a New Drug Target in the Treatment of Metabolic Disorders

JB Hansen, POG Arkhammar… - Current Medicinal …, 2004 - search.proquest.com
The pattern of insulin release is crucial for regulation of glucose and lipid haemostasis.
Deficient insulin release causes hyperglycemia and diabetes, whereas excessive insulin …

Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders

JB Hansen, POG Arkhammar… - Current medicinal …, 2004 - pubmed.ncbi.nlm.nih.gov
The pattern of insulin release is crucial for regulation of glucose and lipid haemostasis.
Deficient insulin release causes hyperglycemia and diabetes, whereas excessive insulin …

[引用][C] Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders

J BONDO HANSEN… - Current medicinal …, 2004 - pascal-francis.inist.fr
Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

[引用][C] Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders

J BONDO HANSEN, POG ARKHAMMAR… - Current medicinal …, 2004 - Bentham